Author

Matthew A. Ingham

Columbia University Irving Medical CenterORCID 0000-0002-5518-8413Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Adina GrunniD· 1 shared Andrea CalifanoiD· 1 shared Arsenije KojadinoviciD· 1 shared Charles KaraniD· 1 shared Cristina I. CaescuiD· 1 shared Denisse EvansiD· 1 shared Gary K. SchwartziD· 1 shared Hanina H. HibshooshiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adina GrunnORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 12, 2025

Systematic elucidation and pharmacologic targeting of non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor

Prabhjot Singh Mundi, Adina Grunn, Arsenije Kojadinovic…·Andrea Califano

This study identifies non-oncogene dependencies in imatinib-resistant GIST using network-based methods and validates six drugs that reverse MR activity in preclinical models.

DOI 10.1101/2025.10.12.681609

humanbulk RNA-seq

𝕏 PostBluesky